Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011

M. R. Jordan; D. E. Bennett; M. A. Wainberg; D. Havlir; S. Hammer; C. Yang; L. Morris; M. Peeters; A. M. Wensing; N. Parkin; J. B. Nachega; A. Phillips; Andrea De Luca; E. Geng; A. Calmy; E. Raizes; P. Sandstrom; C. P. Archibald; J. Perriëns; C. M. Mcclure; S. Y. Hong; J. H. Mcmahon; N. Dedes; D. Sutherland; S. Bertagnolio

doi:10.1093/cid/cis206

Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011

M. R. Jordan, D. E. Bennett, M. A. Wainberg, D. Havlir, S. Hammer, C. Yang, L. Morris, M. Peeters, A. M. Wensing, N. Parkin, J. B. Nachega, A. Phillips, Andrea De Luca, E. Geng, A. Calmy, E. Raizes, P. Sandstrom, C. P. Archibald, J. Perriëns, C. M. McclureS. Y. Hong, J. H. Mcmahon, N. Dedes, D. Sutherland, S. Bertagnolio

Università Cattolica del Sacro Cuore

Research output: Contribution to journal › Article

47 Citations (Scopus)

Abstract

The HIV drug resistance (HIVDR) prevention and assessment strategy, developed by the World Health Organization (WHO) in partnership with HIVResNet, includes monitoring of HIVDR early warning indicators, surveys to assess acquired and transmitted HIVDR, and development of an accredited HIVDR genotyping laboratory network to support survey implementation in resource-limited settings. As of June 2011, 52 countries had implemented at least 1 element of the strategy, and 27 laboratories had been accredited. As access to antiretrovirals expands under the WHO/Joint United Nations Programme on HIV/AIDS Treatment 2.0 initiative, it is essential to strengthen HIVDR surveillance efforts in the face of increasing concern about HIVDR emergence and transmission.

Original language	English
Pages (from-to)	S245-S245-9
Journal	Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Volume	54 Suppl 4
DOIs	https://doi.org/10.1093/cid/cis206
Publication status	Published - 2012

Keywords

Anti-Retroviral Agents
Developing Countries
Drug Resistance, Viral
HIV Infections
Health Policy
Health Surveys
Humans
World Health
World Health Organization

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/cid/cis206

Cite this

Jordan, M. R., Bennett, D. E., Wainberg, M. A., Havlir, D., Hammer, S., Yang, C., Morris, L., Peeters, M., Wensing, A. M., Parkin, N., Nachega, J. B., Phillips, A., De Luca, A., Geng, E., Calmy, A., Raizes, E., Sandstrom, P., Archibald, C. P., Perriëns, J., ... Bertagnolio, S. (2012). Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 54 Suppl 4, S245-S245-9. https://doi.org/10.1093/cid/cis206

@article{9d824e68fd79492bb7ce6b1255e5ef50,

title = "Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011",

abstract = "The HIV drug resistance (HIVDR) prevention and assessment strategy, developed by the World Health Organization (WHO) in partnership with HIVResNet, includes monitoring of HIVDR early warning indicators, surveys to assess acquired and transmitted HIVDR, and development of an accredited HIVDR genotyping laboratory network to support survey implementation in resource-limited settings. As of June 2011, 52 countries had implemented at least 1 element of the strategy, and 27 laboratories had been accredited. As access to antiretrovirals expands under the WHO/Joint United Nations Programme on HIV/AIDS Treatment 2.0 initiative, it is essential to strengthen HIVDR surveillance efforts in the face of increasing concern about HIVDR emergence and transmission.",

keywords = "Anti-Retroviral Agents, Developing Countries, Drug Resistance, Viral, HIV Infections, Health Policy, Health Surveys, Humans, World Health, World Health Organization, Anti-Retroviral Agents, Developing Countries, Drug Resistance, Viral, HIV Infections, Health Policy, Health Surveys, Humans, World Health, World Health Organization",

author = "Jordan, {M. R.} and Bennett, {D. E.} and Wainberg, {M. A.} and D. Havlir and S. Hammer and C. Yang and L. Morris and M. Peeters and Wensing, {A. M.} and N. Parkin and Nachega, {J. B.} and A. Phillips and {De Luca}, Andrea and E. Geng and A. Calmy and E. Raizes and P. Sandstrom and Archibald, {C. P.} and J. Perri{\"e}ns and Mcclure, {C. M.} and Hong, {S. Y.} and Mcmahon, {J. H.} and N. Dedes and D. Sutherland and S. Bertagnolio",

year = "2012",

doi = "10.1093/cid/cis206",

language = "English",

volume = "54 Suppl 4",

pages = "S245--S245--9",

journal = "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",

}

Jordan, MR, Bennett, DE, Wainberg, MA, Havlir, D, Hammer, S, Yang, C, Morris, L, Peeters, M, Wensing, AM, Parkin, N, Nachega, JB, Phillips, A, De Luca, A, Geng, E, Calmy, A, Raizes, E, Sandstrom, P, Archibald, CP, Perriëns, J, Mcclure, CM, Hong, SY, Mcmahon, JH, Dedes, N, Sutherland, D & Bertagnolio, S 2012, 'Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011', Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol. 54 Suppl 4, pp. S245-S245-9. https://doi.org/10.1093/cid/cis206

TY - JOUR

T1 - Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011

AU - Jordan, M. R.

AU - Bennett, D. E.

AU - Wainberg, M. A.

AU - Havlir, D.

AU - Hammer, S.

AU - Yang, C.

AU - Morris, L.

AU - Peeters, M.

AU - Wensing, A. M.

AU - Parkin, N.

AU - Nachega, J. B.

AU - Phillips, A.

AU - De Luca, Andrea

AU - Geng, E.

AU - Calmy, A.

AU - Raizes, E.

AU - Sandstrom, P.

AU - Archibald, C. P.

AU - Perriëns, J.

AU - Mcclure, C. M.

AU - Hong, S. Y.

AU - Mcmahon, J. H.

AU - Dedes, N.

AU - Sutherland, D.

AU - Bertagnolio, S.

PY - 2012

Y1 - 2012

N2 - The HIV drug resistance (HIVDR) prevention and assessment strategy, developed by the World Health Organization (WHO) in partnership with HIVResNet, includes monitoring of HIVDR early warning indicators, surveys to assess acquired and transmitted HIVDR, and development of an accredited HIVDR genotyping laboratory network to support survey implementation in resource-limited settings. As of June 2011, 52 countries had implemented at least 1 element of the strategy, and 27 laboratories had been accredited. As access to antiretrovirals expands under the WHO/Joint United Nations Programme on HIV/AIDS Treatment 2.0 initiative, it is essential to strengthen HIVDR surveillance efforts in the face of increasing concern about HIVDR emergence and transmission.

AB - The HIV drug resistance (HIVDR) prevention and assessment strategy, developed by the World Health Organization (WHO) in partnership with HIVResNet, includes monitoring of HIVDR early warning indicators, surveys to assess acquired and transmitted HIVDR, and development of an accredited HIVDR genotyping laboratory network to support survey implementation in resource-limited settings. As of June 2011, 52 countries had implemented at least 1 element of the strategy, and 27 laboratories had been accredited. As access to antiretrovirals expands under the WHO/Joint United Nations Programme on HIV/AIDS Treatment 2.0 initiative, it is essential to strengthen HIVDR surveillance efforts in the face of increasing concern about HIVDR emergence and transmission.

KW - Anti-Retroviral Agents

KW - Developing Countries

KW - Drug Resistance, Viral

KW - HIV Infections

KW - Health Policy

KW - Health Surveys

KW - Humans

KW - World Health

KW - World Health Organization

KW - Anti-Retroviral Agents

KW - Developing Countries

KW - Drug Resistance, Viral

KW - HIV Infections

KW - Health Policy

KW - Health Surveys

KW - Humans

KW - World Health

KW - World Health Organization

UR - http://hdl.handle.net/10807/40454

U2 - 10.1093/cid/cis206

DO - 10.1093/cid/cis206

M3 - Article

VL - 54 Suppl 4

SP - S245-S245-9

JO - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

JF - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

ER -

Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this